GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Weed Inc (OTCPK:BUDZ) » Definitions » COGS-to-Revenue

Weed (BUDZ) COGS-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Weed COGS-to-Revenue?

Weed's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.00 Mil. Its Revenue for the three months ended in Mar. 2024 was $0.00 Mil.

Weed's COGS to Revenue for the three months ended in Mar. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Weed's Gross Margin % for the three months ended in Mar. 2024 was N/A%.

Weed COGS-to-Revenue Historical Data

The historical data trend for Weed's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Weed COGS-to-Revenue Chart

Weed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Weed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Weed COGS-to-Revenue Calculation

Weed's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

Weed's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Weed  (OTCPK:BUDZ) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Weed's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Weed COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Weed's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Weed (BUDZ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Weed Inc (OTCPK:BUDZ) » Definitions » COGS-to-Revenue
Comparable Companies
UNRV ACRX RLBD SBFM GHSI SHPH ACOR EDXC FLGC CVSI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
4920 North Post Trail, Tucson, AZ, USA, 85750
Website
https://www.weedincusa.com
Weed Inc is working on or planning for several different business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations, and harvest for research, product development, processing, and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the Medical Cannabis and Hemp global market space.
Executives
Nicole M Breen director, 10 percent owner, officer: Secretary/Treasurer 4920 N. POST TRAIL, TUCSON AZ 85750
Elliot Kwestel director 5 AUERBACH LANE, LAWRENCE NY 11559
Lawrence G Dykers director 11924 N CENTAURUS PLACE, ORO VALLEY AZ 85737
Glynn A Burkhardt director, 10 percent owner, officer: Senior Vice President 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Roger Mccaslin director 11924 N. CENTAURUS PLACE, ORO VALLEY AZ 85737
Glenn E. Martin director, 10 percent owner, officer: President and Chairman of BOD 4920 N. POST TRAIL, TUCSON AZ 85750
Robert A Metz director, officer: Vice President 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Robert A Leitzman director, officer: CFO, CAO and V.P. 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Glynn A. Burkhardt director, 10 percent owner, officer: Senior V.P. 11924 N. CENTAURUS PLACE, ORO VALLEY AZ 85737
Donald J Steinberg director, officer: Former Officer and Director 3223 SUMAC ROAD, FALLBROOK CA 92028